medigraphic.com
Instituto Nacional de Salud Pública

2003, Number 3

<< Back Next >>

salud publica mex 2003; 45 (3)

Severe Acute Respiratory Syndrome: A Global View of the Epidemic

Franco-Paredes C, Kuri-Morales P, Álvarez-Lucas C, Palacios-Zavala E, Nava-Frías M, Betancourt-Cravioto M, Santos-Preciado JI, Tapia-Conyer R

Language: Spanish
References: 40
Page: 211-220
PDF size: 113.30 Kb.


ABSTRACT

In early February 2003, the World Health Organization (WHO) began receiving reports of patients with a syndrome characterized by an atypical pneumonia with rapid progression to respiratory failure without an identified cause despite extensive diagnostic workups. Most of these reports pointed out that the outbreak started in Southern China, specifically in the Guandong Province. The initial outbreak in South East Asia has already spread to other Regions in Asia, Europe, North and South America, and South Africa. Many of these cases can be linked through chains of transmission to an index case from the Guandong Province who visited Hong Kong. Although the exact mode of transmission has not been clearly established, the etiology of this syndrome has already been identified. A novel Coronavirus has been identified by electron microscopy and molecular assays in multiple laboratories from respiratory specimens throughout the world. The syndrome has been defined as SARS (Severe Acute Respiratory Syndrome) by WHO, and is characterized by an incubation period between 1 and 10 days (average 5 days) and by a febrile phase that usually lasts approximately 3 days. During the respiratory phase that begins around day 3, patients start developing a dry cough, shortness of breath and hypoxemia. Mechanical ventilatory support is required in about 10 to 40% of cases and the case-fatality rate ranges between 3 and 16%. The laboratory findings in SARS cases include leukopenia, thrombocytopenia, and a rise in transaminases and lactic dehydrogenase levels. Treatment of SARS includes supportive measures and the empiric use of ribavirin. Respiratory isolation, use of respiratory masks, and compulsory hand hygiene constitute the principal preventive measures. The confirmation of a case can be performed at reference laboratories by serologic and molecular assays. From the onset of this epidemic Mexico established a surveillance system as well as clinical guidelines and recommendations for the identification, prevention of secondary spread, and medical management of suspicious and probable cases by health care personnel.


REFERENCES

  1. Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003;78:81-83.

  2. Drazen JM. Case clusters of the severe acute respiratory syndrome. N Engl J Med 2003;348(20):6-7; versión electrónica (marzo 31 de 2003). Disponible en: http://www.nejm.com(10.1056/NEJMe030062).

  3. CDC Update: Outbreak of severe acute respiratory syndrome—Worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003;52(13):269-272.

  4. Gerberding JL. Faster...but fast enough? Responding to the epidemic of severe acute respiratory syndrome. N Engl J Med 2003;348(20):2030-2031; versión electrónica (abril 12 de 2003). Disponible en: http://www.nejm.com(10.1056/NEJMe030067).

  5. CDC Update: Outbreak of severe acute respiratory syndrome—Worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003;529(12):241-248.

  6. News Lancet. Beijing doctor alleges SARS cases cover-up in China. Lancet 2003;361(9366):1357.

  7. Kahn J. China discovers medical secrecy is expensive. New York Times 2003 April 17.

  8. Falsey AR, Walsh EE. Novel Coronavirus and severe acute respiratory syndrome. Lancet 2003;36(9366):1312-1313; versión electrónica (abril 8 de 2003). Disponible en: http://image.thelancet.com/extras/03cm+8/neb.port.

  9. World Health Organization. Cumulative number of reported cases of severe acute respiratory syndrome (3 de abril de 2003). Disponible en: http://www.who.int/esr/sarscountry/2003_04_03/en/.

  10. World Health Organization. Severe acute respiratory syndrome Homepage. Disponible en: http://www.who.int/csr/sars/en/

  11. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348(20):1995-2005; versión electrónica (marzo 31 de 2003). Disponible en: http://www.nejm.com(10.1056/NEJMoa030634).

  12. Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chang-Yeung M et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348(20):1977-1985; versión electrónica (marzo 31 de 2003). Disponible en: http://www.nejm.org(10.1056/NEJMoa030666).

  13. CDC. Preliminary clinical description of severe acute respiratory syndrome. MMWR Morb Mortal Wkly Rep 2003;52(12):255-256.

  14. Pearson H. Mystery virus slow to yield its identity as patient numbers rise. Nature 2003;422(364):423-424; versión electrónica, (marzo 27 de 2003). Disponible en: http://www.nature.com(doi.10.1038/42324).

  15. Bolvin G, Abed Y, Pelletier G. Virological features and clinical manifestations associated with human metaneumovirus: A new Paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002;186:1330-1334.

  16. Stockton J, Stephenson I, Fleming D, Zambon M. Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg Infect Dis 2002;8(9):84.

  17. Ksiazek TG, Erdman D, Goldsmith C, Zaki SR, Peret T, Emery S et al. A novel Coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1953-1966; versión electrónica (abril 10 de 2003). Disponible en: http://www.nejm.com(10.1056/NEJMoa030781).

  18. Drosten C, Gunther C, Preiser W, van der Werf S, Hans-Reinhard B, Becker S et al. Identification of a novel Coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1967-1976; versión electrónica, (abril 16 de 2003). Disponible en: http://www.nejm.com(10.1056/NEJMoa030747v2.pdf).

  19. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-1325; versión electrónica (abril 8 de 2003). Disponible en: http://image.thelancet.com/extras/03art3477web.pdf.

  20. Fouchier RA, Kuiken T, Schutten M, Van Amerongen G, Van Doornum GJ, Bernadette G et al. Aetiology: Koch’s postulates fulfilled for SARS virus. Nature 2003; 423(240): 333-340; versión electrónica (mayo 15 de 2003). Disponible en: http://www.nature.com(doi:10.1038/423240ª).

  21. NaaNes M. U.S. Immunization News. LSU Professor hopes to develop vaccine against SARS. Baton Rouge Advocate. Versión electrónica (abril 24 de 2003). Disponible en: http://www.theadvocate.com.

  22. WHO. Severe Acute Respiratory Syndrome (SARS)-multi-country outbreak-Update 30. Status of diagnostic tests, significance of “super spreaders”, situation in China. Versión electrónica (abril 15, 2003). Disponible en: http://www.who.int/csr/don2003_04_15/en/.

  23. CDC. Update. Severe acute respiratory syndrome. United States. 2003. MMWR Morb Mortal Wkly Rep 2003; 52 (15):332-336.

  24. News Lancet. Global update on SARS cases. Lancet 2003;361(9366):1289.

  25. CDC. Diagnosis/Evaluation of severe acute respiratory syndrome (SARS). CDC website: http://www.cdc.gov/ncidod/sars/diagnosis.htm.

  26. Masur H, Ezequiel E, Lane CH. Severe acute respiratory syndrome. Providing care in the face of uncertainty. JAMA 2003;289(21):10-12.

  27. Cyranoski D, Abbot A. Apartment complex holds clues to pandemic potential of SARS. Nature 2003;3-4; versión electrónica (mayo 1 de 2003). Disponible en: http://www.nature.com(doi:10.1038/423003a).

  28. CDC. Update. Severe acute respiratory syndrome: United States, May 21, 2003;52(20):466-468.

  29. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289(21):1-8.

  30. Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361:1761-1766; version electrónica (mayo 17 de 2003). Disponible en: (http://image.thelancet.com/extras/03art4453web.pdf).

  31. Hon KL, Leung CW, Cheng WT, Chan PK, Chu WC, Kwan YW et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003;361:1701-1703; version electrónica (abril 29 de 2003). Disponible en: http://image.thelancet.com/extras/03let4127web.pdf.

  32. Ordan O, Rotem R, Jaspers I, Fiescher E. Stress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma acellular proliferation. Br J Pharmacol 2003:138: 1156-1162.

  33. McGilvray ID, Lu Z, Dackiw AP, Marshall JC, Kapus A, et al. Murine hepatitis virus strain-3 induces the macrophage prothrombinase fgl-2 through p38 mitogen-activated protein-kinase activation. J Biol Chem 1998;273(48):1156-1162.

  34. Anand KZ, Washwani P, Mesters JR, Hilgenfeld R. Coronavirus mainproteinase (3Clpro) structure: Basis for design of anti-SARS drugs. Science 2003; versión electrónica (13 de mayo de 2003). Disponible en: http://www.sciencemag.org(doi.1126/science.1084658).

  35. Nicholss JM, Poon LLM, Lu KC, Wai FN, Loung CY, Hui PK et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361:1773-1778; versión electrónica (16 de mayo de 2003). Disponible en: http://image.thelancet.com/extras/03art4347web.pdf.

  36. Ho W. Guidelines on management of severe acute respiratory syndrome (SARS). Lancet 2003;361:1313-1314; versión electrónica (8 de abril de 2003). Disponible en: http://image.thelancet.com/extras/03cmt89web.pdf.

  37. Sing Tao LI T, Buckley TA, Yap FHY, Sung JJY, Joynt GM. Severe acute respiratory syndrome (SARS) Infection Control. Lancet 2003;361:1386-1387.

  38. CDC. Updated interim domestic infection control guidance in the health care and community settings for patients with suspected SARS. Versión electrónica (April 25, 2003). Disponible en: http://www.cdc.gov/sars.

  39. Health Canada. Cluster of severe acute respiratory syndrome cases among protected health care workers – Toronto, April 2003. Canada Communicable Disease Report; versión electronica (18 de abril de 2003). Disponible en: http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/ccdrrmtc/ 03vol29/prev/dr-sars0515.html.

  40. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM et al. A major outbreak of SARS in Hong Kong. N Engl J Med 2003;348(20):1986-1994; versión electrónica (16 de abril de 2003). Disponible en: http://www.nejm.com(10.1056)/NEJMoa030685).




2020     |     www.medigraphic.com